| • Science | • People | • Locations | • Timeline |
| Contents | ||
|
| |
| IUPAC name: (5α,6α)-7,8-didehydro-4,5-epoxy- | |
| CAS number 561-27-3 | ATC code N02AA09 |
| Chemical formula | C21 H23 N O5 |
| Molecular weight | 369.42 |
| BioavailabilityIn pharmacology, bioavailability is a term used to describe a pharmacokinetic property of drugs, namely, the fraction of a dose which reaches the systemic circulation. It is an essential tool in pharmacokinetics, as bioavailability must be considered when | ? |
| Metabolism | ? |
| Elimination half life | 3 minutes |
| ExcretionExcretion is the biological process by which an organism separates waste products from its body. The waste products are then usually expelled from the body by elimination''. In mammals, for example, the two major excretory processes are the formation of u | ? |
| Pregnancy categoryThe pregnancy category of a pharmaceutical agent is an assessment of the risk of fetal injury due to the pharmaceutical, if it is used as directed by the mother. It does not include any risks conferred by pharmaceutical agents or their metabolites that ar | ? |
| Legal status | Schedule I ( USA) |
| Delivery | Vaporized, Insufflated , Injected, Taken Orally |
Indicated for:
Recreational uses: Unethical uses:
Other uses:
|
Contraindications:
|
| Side effects:
Eye:
Skin:
Urogenital and reproductive:
Miscellaneous:
|